China Universal Asset Management Co., Ltd. Rocket Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q2 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 21,639 shares of RCKT stock, worth $68,162. This represents 0.01% of its overall portfolio holdings.
Number of Shares
21,639
Previous 21,388
1.17%
Holding current value
$68,162
Previous $142,000
62.68%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding RCKT
# of Institutions
221Shares Held
98.4MCall Options Held
611KPut Options Held
474K-
Rtw Investments, LP New York, NY17.7MShares$55.7 Million0.67% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.36MShares$26.3 Million0.35% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$19.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.12MShares$19.3 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.82MShares$15.2 Million0.17% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $238M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...